Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services.
The company serves customers working in pharmaceutical and biotech companies, hospitals an…
Analysis
Middle-of-the-road
Thermo Fisher Scientific Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is fair. You pay 21.7× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone. At today's price, the market is assuming roughly 7% yearly growth; analysts expect 9%. The price, in other words, assumes less than the experts do.
The trajectory is moderate and the balance sheet is adequate. The company scores 8/20 on our value-creation score: creating some value.
What to watch: A large part of the company's book value is the price paid for past acquisitions. Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202369
100
2023202420252026
All-time high
100
Jun 2026
All-time low
43
Jan 2024
Average rank
81
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
53
42
40
62
Price/Earnings
43
62
61
53
Price/Book
51
45
33
30
Dividend Yield
88
76
79
76
Value (overall)
88
83
78
83
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.